Owlstone Medical and Mayo Clinic Collaborate to Develop Pre-Endoscopic Test to Improve Effectiveness of Colonoscopy


Pilot study demonstrates FAIMS technology is able to detect patients inadequately prepped prior to colonoscopy with 100% sensitivity Owlstone Medical, a diagnostics company developing a breathalyzer for disease, today announced it has entered into collaboration with Mayo Clinic, the leading US non-profit medical practice, education, and medical research group. The company’s FAIMS technology is being …




Continue reading

Why did the ducklings cross the road?


We get all sorts of visitors to the Science Park and not just the two legged kind. Recently we’ve had Redwings and now we have some rather charming ducks pay us a visit. We thought you might like to read what Graham, one of Abbey Security team, told us about his experience with a family of …




Continue reading

Third Queen’s Award win


Cambridge Consultants wins International Trade award for growth in overseas markets Product design and development firm Cambridge Consultants has won a Queen’s Award for Enterprise in International Trade. The accolade is in recognition of the success of the company’s ambitious growth strategy, which has seen overseas sales grow by 74 per cent since 2012. Overseas …




Continue reading

FactBio moves to Cambridge Science Park and expands team


FactBio, a developer of novel bioinformatics software with a focus on improving knowledge management and data sharing, has moved to new offices in Cambridge. Alongside the move to the new offices in the Innovation Centre on the Cambridge Science Park, FactBio has hired additional staff to support the development of Kusp, its data curation and …




Continue reading

Engineering the future


Tim Fell and Richard Hammond

New partnership set to transform the engineering of biology   Product design and development firm Cambridge Consultants is joining forces with innovative software company Synthace in an ambitious bid to unlock the full potential of biology to address many of the global challenges facing the world. The partnership is aimed at boosting adoption of a …




Continue reading

Aviva Invests in Owlstone Medical Breath Biopsy platform


Investment will drive adoption of new diagnostic modality within healthcare system Cambridge, UK, 27 March 2017: Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today announced an investment from Aviva Ventures, the venture capital arm of Aviva plc, a global leader in insurance. The investment takes Owlstone Medical’s total funding to $23.5 …




Continue reading

Owlstone Medical Opens New High Volume Breath Biopsy Lab with Tony Blair Visit


New facilities will enable high quality and high throughput Biomarker Services, for identification of novel breath biomarkers in disease diagnostics and precision medicine applications Cambridge, UK, 17 March 2017: Owlstone Medical Ltd, a diagnostics company developing a breathalyzer for disease, today welcomed Tony Blair to its headquarters in Cambridge, UK where he officially opened the …




Continue reading